Does Cediranib Prevent Bowel Perforation in Platinum-resistant Ovarian Cancer

Clinical trial NCT07648745 · COMPLETED

Trial details

NCT number: NCT07648745
Sponsor: Prof Gordon Jayson
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bowel Obstruction Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2018-05-14
Primary completion: 2025-01-14
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.